These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32869682)
1. Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil. Pompei LM; Wender MCO; de Melo NR; Kulak J; Pardini D; Machado RB; Fernandes CE; Palacios S; Nappi RE Climacteric; 2021 Apr; 24(2):157-163. PubMed ID: 32869682 [TBL] [Abstract][Full Text] [Related]
2. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America. Nappi RE; de Melo NR; Martino M; Celis-González C; Villaseca P; Röhrich S; Palacios S Climacteric; 2018 Aug; 21(4):397-403. PubMed ID: 29741110 [TBL] [Abstract][Full Text] [Related]
3. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey. Nappi RE; Kokot-Kierepa M Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244 [TBL] [Abstract][Full Text] [Related]
4. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Simon JA; Kokot-Kierepa M; Goldstein J; Nappi RE Menopause; 2013 Oct; 20(10):1043-8. PubMed ID: 23571518 [TBL] [Abstract][Full Text] [Related]
5. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319 [TBL] [Abstract][Full Text] [Related]
6. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study. Utian WH; Maamari R Climacteric; 2014 Feb; 17(1):29-36. PubMed ID: 24083795 [TBL] [Abstract][Full Text] [Related]
7. The CLOSER survey: impact of postmenopausal vaginal discomfort on women and male partners in the UK. Domoney C; Currie H; Panay N; Maamari R; Nappi RE Menopause Int; 2013 Jun; 19(2):69-76. PubMed ID: 23778561 [TBL] [Abstract][Full Text] [Related]
8. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. Kingsberg SA; Wysocki S; Magnus L; Krychman ML J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050 [TBL] [Abstract][Full Text] [Related]
9. Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study. Domoney C; Short H; Particco M; Panay N Post Reprod Health; 2020 Jun; 26(2):101-109. PubMed ID: 32627698 [TBL] [Abstract][Full Text] [Related]
10. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs. Nappi RE; Palacios S; Particco M; Panay N Maturitas; 2016 Sep; 91():81-90. PubMed ID: 27451325 [TBL] [Abstract][Full Text] [Related]
11. Women's voices in the menopause: results from an international survey on vaginal atrophy. Nappi RE; Kokot-Kierepa M Maturitas; 2010 Nov; 67(3):233-8. PubMed ID: 20828948 [TBL] [Abstract][Full Text] [Related]
12. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Nappi RE; Palacios S; Panay N; Particco M; Krychman ML Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580 [TBL] [Abstract][Full Text] [Related]
13. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe. DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981 [TBL] [Abstract][Full Text] [Related]
14. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey. Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM Maturitas; 2016 Sep; 91():74-80. PubMed ID: 27451324 [TBL] [Abstract][Full Text] [Related]
15. Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data. Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM Gynecol Endocrinol; 2017 May; 33(5):389-394. PubMed ID: 28277131 [TBL] [Abstract][Full Text] [Related]
16. Medical and patient attitude towards vaginal atrophy: the AGATA study. Palma F; Della Vecchia E; Cagnacci A; Climacteric; 2016 Dec; 19(6):553-557. PubMed ID: 27736240 [TBL] [Abstract][Full Text] [Related]
17. An individualized approach to the management of vaginal atrophy in Latin America. Palacios S; Nappi RE; Shapiro M; de Melo NR; Wender MCO; Fernandes CE; Pardini D; Machado RB; Kulak J; Celis-González C; Martino MT; Pizzi RR; Villaseca P; Storch E; Danckers LF; Hernández-Bueno JA Menopause; 2019 Aug; 26(8):919-928. PubMed ID: 31188288 [TBL] [Abstract][Full Text] [Related]
18. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy. Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488 [TBL] [Abstract][Full Text] [Related]
19. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Freedman MA Womens Health (Lond); 2014 Jul; 10(4):445-54. PubMed ID: 25259904 [TBL] [Abstract][Full Text] [Related]
20. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]